Bret Wilshere

Five Below Inc (NASDAQ:FIVE): Can the Stock Surprise in Next Earnings?

Five Below Inc (NASDAQ:FIVE) plunged -0.69% or -0.27 points during previous trade after opening at the price of $39.35, a total of 1.64M shares exchanged hands compared with its average trading volume of 1.21M shares. The stock has a market capitalization of $2.13B and it has 54.88M outstanding shares.

According to consensus agreement of 16 analysts Five Below Inc (NASDAQ:FIVE) will report earnings per share of $0.89 in their quarterly report and it is expected to announce the company’s results on 3/22/17 After Market Close. The stock lost almost -1.9% in price since last earning report, when its share price was $39.88. For the current quarter the company has highest EPS estimates of $0.89 and low forecast is $0.88. However a year ago for the same quarter the company has reported $0.77 earnings per share.

Earnings reaction history indicates that share price went up 11 times out of last 18 quarters. In Five Below Inc (NASDAQ:FIVE)’s last 12 earnings reports, it has beaten EPS estimates 83% of the time. However it has meet the estimates 2 times and missed 0 time.

If we have a peek on EPS and surprise factor history during last four quarters, for the previous quarter ended on 10/2016, the consensus mean EPS was $0.09 while Five Below Inc (NASDAQ:FIVE) reported $0.10 EPS on 12/1/2016 After Market Close with a difference of 0.01 marking a surprise factor of 11.11%. The stock’s next day closing price was $43.82 with the gain of 9.88% in its share price. On seventh day of the earnings report price change of the stock was 8.17%.

Previously for the quarter ended on 7/2016, Five Below Inc (NASDAQ:FIVE)’s expected mean EPS was $0.17, the company reported its quarterly earnings per share of $0.18 on 8/31/2016 After Market Close, beating the analysts’ consensus estimate by 0.01 with surprise factor of 5.88%. The stock’s closing price was $44.05 with the loss of -1.14% in its share price on the day following the earning announcement. However price change of the stock was 0.00% on seventh day of the earnings report.

Five Below Inc (NASDAQ:FIVE)’s mean EPS estimate was $0.10 for the quarter ended on 4/2016, while it reported EPS of $0.12 on 6/2/2016 After Market Close, beating the analysts’ consensus estimate by 0.02 with surprise factor of 20.00%. On next day when data was publically announced, the stock’s closing price was $43.74 with 2.08% gain in its share price. On seventh day of the earnings report price change of the stock was up 5.34%.

Back on 3/22/2016 the company’s estimated EPS value was $0.76 and it reported $0.77 earnings per share (EPS) for the quarter ended on 1/2016. The company posted a positive surprise factor of 1.32% by 0.01.

Average EPS forecast for the current year is $1.29 according to 16 analysts making projections for Five Below Inc (NASDAQ:FIVE). The most expectant earnings per share estimate of the stock is set at $1.3 while the conservative estimates kept at $1.29 over the current year. Having a look at the historical EPS report, the company attained $1.05 EPS for the previous year. While revenue estimates for the current year is $999.81M, Five Below Inc (NASDAQ:FIVE) setting the highest revenues estimates of $1B and indicating lowest revenues at $998.9M according to agreement of 15 number of analysts. Current quarter revenue movements show that, the company has set average revenue estimates of $387.63M covering forecast of 13 analysts. The company indicates a peak revenue level of $389.41M and $386.6M at bottom level.

Having a glance at growth estimates of the company, it has current quarter growth estimates of 15.60% whereas for next quarter it has 16.70% estimations over growth. Its forecasts over growth are 22.90% during current year while analysts’ growth estimation for the next year is 22.50%. Past 5 years growth of Five Below Inc (NASDAQ:FIVE) observed at 23.36%, and for the next five years the analysts that follow this company are expecting its growth at 22.03%.

Five Below Inc (NASDAQ:FIVE) reached at $38.85 price level during last trade its distance from 20 days simple moving average is -0.09%, and its distance from 50 days simple moving average is -1.03% while it has a distance of -7.85% from the 200 days simple moving average. One year trading price range hit the peak level of $52.70 and touched the lowest level of $35.03. The company’s distance from 52-week high price is -26.28% and current price is above +10.90% from 52-week low price.

Experts Analysis on Share Price: Monsanto Company (NYSE:MON)

Monsanto Company (NYSE:MON) soared 0.93% during previous trade, a total of 2.17M shares exchanged hands compared with its average trading volume of 2.01M shares whereas its relative volume is 1.18. The stock has a market capitalization of $50.02B along with 438.55M outstanding shares. Stock’s intraday price range hit the peak level of $114.07 and touched the lowest level of $112.56.

Most recently Monsanto Company (NYSE:MON)’s price target was revised on 03/03/17 and according to 16 analysts stock’s price will reach at $121.81 during 52 weeks with standard deviation of 13.53. Stock’s minimum price target estimates has been figured out at $109 while the maximum price target forecast is established at $128, if we look at the price target with an optimistic approach it has upside potential of 12% from its latest closing price of $113.81.

Historically, if we look at price target revisions, three weeks ago Monsanto Company (NYSE:MON)’s price target was revised on 2/23/17 by the analysts, however the bullish price estimates of the stock set at $128 while the bearish estimates kept at $88 over the next one year. Stock’s 52-week target was retained at $118, the estimates indicates a standard deviation of 12.88.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.80. ABR value is precisely based on brokerage recommendations, where out of 10 brokerage recommendations 6 rate Monsanto Company (NYSE:MON) stock a Strong Buy, 0 rate the stocks of the company a Buy, 4 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 1/6/17 the stock of Monsanto Company (NYSE:MON) upgraded by CLSA from Underperform to Outperform. However previously on 9/27/16 it was upgraded by Goldman from Sell to Neutral. A research note issued on 9/26/16 the stock was upgraded by Bernstein from Underperform to Mkt Perform.

Monsanto Company (NYSE:MON) performance over the past one year soared 25.10% whereas its year to date (YTD) performance indicated a bullish trend of 8.73%. During the last six months the stock climbed 11.17%. Quarterly performance of the company shows optimistic momentum of 8.56% while its last one month trend is positive with 4.90%. Stock’s weekly performance expressed down trend of -0.29%.

The company’s price sits 3.16% above from its 50-day moving average of $111.22 and 8.35% far from the stock’s 200-day moving average which is $105.75. Monsanto Company (NYSE:MON)’s shares are currently trading -1.92% away from the 52-week high price of $116.04 and +36.37% far from the 52-week low price of $83.46.

According to consensus agreement of 17 analysts Monsanto Company (NYSE:MON) will report earnings per share of $2.82 in their quarterly report and it is expected to announce the company’s results on 4/5/17 Before Market Open. For the current quarter the company has high EPS estimates of $3.12 in contradiction of low EPS estimates of $2.63. However a year ago for the same quarter the company has reported $2.42 EPS. Current year EPS projections for Monsanto Company (NYSE:MON) set at $4.74 according to the sentiments of 20 analysts, while its lowest earnings estimates are $4.49 and highest earnings estimates are $5.05.

According to 12 analysts, Monsanto Company (NYSE:MON)’s revenue estimates for the current quarter are $4.74B meanwhile the company has high revenue estimates of $4.93B in contradiction of low revenue estimates of $4.56B. For the current year the company’s revenue estimates are $14.1B compared to low analyst estimates of $13.64B and high estimates of $14.65B according to the projection of 16 analysts.

Momentum Stock in Focus: Cempra Inc (NASDAQ:CEMP)

Cempra Inc (NASDAQ:CEMP) share price soared 9.09% or 0.35 points to reach at $4.20 during previous trading session. The stock’s price fluctuated within the range of $3.80 – $4.25 during previous trading session. A total of 1.97M shares exchanged hands, whereas the company’s average trading volume stands at 2.36M shares. Cempra Inc (NASDAQ:CEMP) has a market capitalization of $220.05M and most recently 52.39M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Cempra Inc (NASDAQ:CEMP) is at 66.06.

According to sentiments of 12 analysts the mean estimates of short term price target for the company’s stock is marked at $9.96. The most optimistic analyst sees the stock reaching $40.00 while the most conventional predicts the target price at $2.00.

The consensus means EPS for the current quarter is at -$0.52 derived from a total of 11 estimates. According to analysts minimum EPS for the current quarter is expected at -$0.58 and can go high up to -$0.39. However a year ago during same quarter Cempra Inc (NASDAQ:CEMP) reported -$0.61 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of -$0.33 per share according to consensus of 11 analysts.

According to sentiments of 8 analysts the company is expected to report revenues of $4.82M for the current quarter. Bearish revenue estimates established at $2.5M while the bullish revenue forecast has been figured out at $10.16M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 3.00 on the shares of Cempra Inc (NASDAQ:CEMP). Out of rating recommendations 1 have given the stock a Buy while 1 recommend the stock as Outperform. 10 have given the stock a Hold rating, 1 as Underperform and 1 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Cempra Inc (NASDAQ:CEMP) distance from 20 day simple moving average is 15.98% whereas its distance from 50 day simple moving average is 24.85% along with -68.97% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Cempra Inc (NASDAQ:CEMP) shares were trading -84.42% below from the 52-week high mark of $26.95 and +64.71% above from the 52-week bottom of $2.55. The stock hit its 52-week high price on 09/28/16, and 52-week low price on 12/29/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 12.00% in the past one week and soared 322.28% during previous one month drive, the stock went down -40.00% during past quarter. In the last six months the stock’s performance fell -83.46% while yearly performance of the company fell -71.81%. The company’s year to date (YTD) performance is at 50.00%.

While taking a glance at financials, we can look at a number of key indicators. Cempra Inc (NASDAQ:CEMP) has a Return on Assets (ROA) of -48.20%. The company currently has a Return on Equity (ROE) of -60.20% and a Return on Investment (ROI) of -59.00%. Average true range (ATR-14) of the company sets at 0.30, along with its weekly and monthly volatility of 7.33%, 8.61% respectively. Beta value of the stock stands at 0.97.

The company’s quick ratio for most recent quarter is 8.10 along with current ratio for most recent quarter of 8.10. Total debt to equity ratio of the company for most recent quarter is 0.08 whereas long term debt to equity ratio for most recent quarter is 0.05.

Steady Stock: Cerulean Pharma Inc (NASDAQ:CERU)

Cerulean Pharma Inc (NASDAQ:CERU) share price plunged -62.35% or -2.07 points to reach at $1.25 during previous trading session. The stock’s price fluctuated within the range of $1.06 – $1.45 during previous trading session. A total of 24,509,351 shares exchanged hands, whereas the company’s average trading volume stands at 3.42M shares.

Cerulean Pharma Inc (NASDAQ:CERU) has a market capitalization of $34.30M and most recently 27.44M outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Cerulean Pharma Inc (NASDAQ:CERU) is at 44.18.

According to sentiments of 2 analysts the mean estimates of short term price target for the company’s stock is marked at $3.75. The most optimistic analyst sees the stock reaching $6.00 while the most conventional predicts the target price at $1.50.

The consensus means EPS for the current quarter is at -$0.34 derived from a total of 2 estimates. According to analysts minimum EPS for the current quarter is expected at -$0.37 and can go high up to -$0.3. However a year ago during same quarter Cerulean Pharma Inc (NASDAQ:CERU) reported -$0.39 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of -$0.31 per share according to consensus of 1 analysts.

According to sentiments of 1 analysts the company is expected to report revenues of $5M for the current quarter. Bearish revenue estimates established at $5M while the bullish revenue forecast has been figured out at $5M.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.33 on the shares of Cerulean Pharma Inc (NASDAQ:CERU). Out of rating recommendations 0 have given the stock a Buy while 2 recommend the stock as Outperform. 0 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Cerulean Pharma Inc (NASDAQ:CERU) distance from 20 day simple moving average is -27.26% whereas its distance from 50 day simple moving average is -2.29% along with -11.09% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Cerulean Pharma Inc (NASDAQ:CERU) shares were trading -17.13% below from the 52-week high mark of $4.33 and 98.32% above from the 52-week bottom of $0.63. The stock hit its 52-week high price on 04/21/16, and 52-week low price on 11/08/16.

When we have a peek on stock’s historical trends we come to know that, the stock has slipped -49.80% in the past one week and plunged -11.35% during previous one month drive, the stock went up 66.71% during past quarter. In the last six months the stock’s performance fell 28.87% while yearly performance of the company fell -48.13%. The company’s year to date (YTD) performance is at 76.50%.

While taking a glance at financials, we can look at a number of key indicators. Cerulean Pharma Inc (NASDAQ:CERU) has a Return on Assets (ROA) of -77.90%. The company currently has a Return on Equity (ROE) of -141.70%. Average true range (ATR-14) of the company sets at 0.47, along with its weekly and monthly volatility of 29.03%, 14.70% respectively.

The company’s quick ratio for most recent quarter is 2.50 along with current ratio for most recent quarter of 2.50. Total debt to equity ratio of the company for most recent quarter is 0.89 whereas long term debt to equity ratio for most recent quarter is 0.40.

Analyst Perspectives on Price Target History: Alibaba Group Holding Ltd (NYSE:BABA)

Alibaba Group Holding Ltd (NYSE:BABA) soared 1.55% during previous trade, a total of 12.38M shares exchanged hands compared with its average trading volume of 8.59M shares whereas its relative volume is 1.32. The stock has a market capitalization of $265.28B along with 2.47B outstanding shares. Stock’s intraday price range hit the peak level of $108.20 and touched the lowest level of $105.94.

Most recently Alibaba Group Holding Ltd (NYSE:BABA)’s price target was revised on 3/2/17 and according to 39 analysts stock’s price will reach at $127.15 during 52 weeks with standard deviation of 14.71. Stock’s minimum price target estimates has been figured out at $99.91 while the maximum price target forecast is established at $179.55, if we look at the price target with an optimistic approach it has upside potential of 67% from its latest closing price of $107.25.

Historically, if we look at price target revisions, three weeks ago Alibaba Group Holding Ltd (NYSE:BABA)’s price target was revised on 2/22/17 by the analysts, however the bullish price estimates of the stock set at $140 while the bearish estimates kept at $95 over the next one year. Stock’s 52-week target was retained at $118.63, the estimates indicates a standard deviation of 14.71.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.28. ABR value is precisely based on brokerage recommendations, where out of 16 brokerage recommendations 12 rate Alibaba Group Holding Ltd (NYSE:BABA) stock a Strong Buy, 3 rate the stocks of the company a Buy, 1 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 1/9/17 the stock of Alibaba Group Holding Ltd (NYSE:BABA) upgraded by Standpoint Research from Hold to Accumulate. However previously on 8/12/16 it was upgraded by Raymond James from Outperform to Strong Buy. A research note issued on 8/12/16 the stock was upgraded by Macquarie from Neutral to Outperform.

Alibaba Group Holding Ltd (NYSE:BABA) performance over the past one year soared 40.66% whereas its year to date (YTD) performance indicated a bullish trend of 22.14%. During the last six months the stock climbed 2.49%. Quarterly performance of the company shows optimistic momentum of 20.71% while its last one month trend is positive with 6.38%. Stock’s weekly performance expressed up trend of 1.97%.

The company’s price sits 6.11% above from its 50-day moving average of $102.83 and 13.75% far from the stock’s 200-day moving average which is $99.17. Alibaba Group Holding Ltd (NYSE:BABA)’s shares are currently trading -2.38% away from the 52-week high price of $109.87 and +46.32% far from the 52-week low price of $73.30.

According to consensus agreement of 21 analysts Alibaba Group Holding Ltd (NYSE:BABA) will report earnings per share of $0.71 in their quarterly report and it is expected to announce the company’s results on 5/4/17. For the current quarter the company has high EPS estimates of $0.88 in contradiction of low EPS estimates of $0.58. However a year ago for the same quarter the company has reported $0.44 EPS. Current year EPS projections for Alibaba Group Holding Ltd (NYSE:BABA) set at $3.47 according to the sentiments of 34 analysts, while its lowest earnings estimates are $3.26 and highest earnings estimates are $3.7.

According to 20 analysts, Alibaba Group Holding Ltd (NYSE:BABA)’s revenue estimates for the current quarter are $5.2B meanwhile the company has high revenue estimates of $5.38B in contradiction of low revenue estimates of $5B. For the current year the company’s revenue estimates are $22.6B compared to low analyst estimates of $22.28B and high estimates of $22.99B according to the projection of 33 analysts.

Overbuying Stock Buzz: Philip Morris International Inc. (NYSE:PM)

Philip Morris International Inc. (NYSE:PM) share price soared 0.89% or 1.01 points to reach at $114.01 during previous trading session. The stock’s price fluctuated within the range of $113 – $114.11 during previous trading session. A total of 5.67M shares exchanged hands, whereas the company’s average trading volume stands at 4.66M shares. Philip Morris International Inc. (NYSE:PM) has a market capitalization of $177.34B and most recently 1.55B outstanding shares have been calculated.

In terms of market analysis and trading signals, RSI moving above the horizontal 30 reference level is viewed as a bullish indicator, while the RSI moving below the horizontal 70 reference level is seen to be a bearish indicator. Movements above 70 are interpreted as indicating overbought conditions; conversely, movements under 30 reflect oversold conditions.

Relative strength index (RSI-14) for Philip Morris International Inc. (NYSE:PM) is at 85.71.

According to sentiments of 14 analysts the mean estimates of short term price target for the company’s stock is marked at $109.93. The most optimistic analyst sees the stock reaching $120 while the most conventional predicts the target price at $94.

The consensus mean EPS for the current quarter is at $1.03 derived from a total of 9 estimates. According to analysts minimum EPS for the current quarter is expected at $1 and can go high up to $1.07. However a year ago during same quarter Philip Morris International Inc. (NYSE:PM) reported $0.98 EPS.

For the upcoming quarter, initial predictions are anticipating that the company will post earnings of $1.23 per share according to consensus of 9 analysts.

According to sentiments of 5 analysts the company is expected to report revenues of $6.48B for the current quarter. Bearish revenue estimates established at $6.33B while the bullish revenue forecast has been figured out at $6.66B.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 2.41 on the shares of Philip Morris International Inc. (NYSE:PM). Out of rating recommendations 2 have given the stock a Buy while 6 recommend the stock as Outperform. 9 have given the stock a Hold rating, 0 as Underperform and 0 as Sell.

On technical side, moving averages may help to distinguish direction of tendencies, and they might also be used to set levels of sustenance and resistance. Philip Morris International Inc. (NYSE:PM)’s distance from 20 day simple moving average is 4.31% whereas its distance from 50 day simple moving average is 12.11% along with 17.70% distance from 200 day simple moving average.

An important factor to consider when evaluating a stock’s current and future value are the 52 week price high and low levels. Philip Morris International Inc. (NYSE:PM) shares were trading -0.39% below from the 52-week high mark of $114.46 and +32.89% above from the 52-week bottom of $85.79. The stock hit its 52-week high price on 03/17/17 and 52-week low price on 12/01/16.

When we have a peek on stock’s historical trends we come to know that, the stock has climbed 2.69% in the past one week and soared 10.70% during previous one month drive, the stock went up 28.28% during past quarter. In the last six months the stock’s performance soared 17.88% while yearly performance of the company advanced 21.14%.The company’s year to date (YTD) performance is at 24.61%.

While taking a glance at financials, we can look at a number of key indicators. Philip Morris International Inc. (NYSE:PM) has a Return on Assets (ROA) of 19.60%. The company currently has a Return on Equity (ROE) of -55.40% and a Return on Investment (ROI) of 49.10%. Average true range (ATR-14) of the company sets at 1.21, along with its weekly and monthly volatility of 1.17%, 1.14% respectively. Beta value of the stock stands at 0.95.

The company’s price to free cash flow for trailing twelve months is 355.62. Its quick ratio for most recent quarter is 0.50 along with current ratio for most recent quarter of 1.10.

Bonanza Creek Energy Inc (NYSE:BCEI) to Report Quarterly Earnings: What’s in the Cards?

Shares of Bonanza Creek Energy Inc (NYSE:BCEI) jumped 5.00% to reach at $1.05 during previous trading session. The company has experienced volume of 1.20M shares while on average the company has a capacity of trading 1.25M share.

Bonanza Creek Energy Inc (NYSE:BCEI) on March 16, 2017 announced its fourth quarter and full year 2016 financial and operating results.

For the fourth quarter of 2016, the Company reported reduced production volumes on a sequential and annual basis due to inactivity. At the end of the first quarter of 2016, the Company released its last drilling rig and suspended drilling and completion operations. Since the beginning of the second quarter, the Company has focused efforts on maximizing production from PDP wells, meeting or beating the midpoint of its production guidance range in each quarter of 2016. Realized pricing before the effects of derivative activity was stronger in the fourth quarter of 2016 compared to the previous quarter resulting in a moderated decrease to top line revenue on a sequential basis. For the full year of 2016, the Company reported reduced revenues due to both decreased production volumes as well as weaker realized pricing when compared to the 2015 fiscal year.

Reported net loss for the fourth quarter of 2016 was $67.3 million, or $1.37 per diluted share, compared to a net loss of $573.7 million, or $12.08 per diluted share, for the fourth quarter of 2015. The quarterly GAAP net loss for 2015 was driven largely by total property impairments of $585.6 million. Adjusted net loss for the fourth quarter of 2016 was $27.9 million, or $0.57 per diluted share, compared to adjusted net loss of $8.4 million, or $0.17 per diluted share for the fourth quarter of 2015.

Adjusted EBITDAX for the fourth quarter of 2016 was $14.5 million, a 78% decrease compared to $67.1 million for the fourth quarter of 2015.

Bonanza Creek Energy Inc (NYSE:BCEI) holds the market capitalization of $48.30M along with 49.68M outstanding shares. During the last trade, stock’s minimum price has been reached out at $0.99 while the maximum trading price moved at $1.06. Currently the stock price is moving -77.52% off from the highest level of twelve months and +75.00% above from twelve months low. Bonanza Creek Energy Inc (NYSE:BCEI) marked 52-week highest price level of $4.67 on 04/28/16 and 52-week lowest price level of $0.60 on 08/02/16. For the stock, price target value has been calculated at $1.08 based on calls of 7 experts. Stock’s minimum price target estimates has been figured out at $0.50 while the maximum price target forecast is established at $1.57.

As of current trade, Bonanza Creek Energy Inc (NYSE:BCEI) has shown weekly downbeat performance of -12.50%. Its six months performance indicated a bearish movement while its yearly performance reflected a negative trend of -44.44%. Year-to-date (YTD) performance of the stock illustrate upbeat trend of 2.94%. Shares of Bonanza Creek Energy Inc (NYSE:BCEI) currently have an ABR of 3.75, derived from a total of 8 opinions. The company’s price sits -46.57% below from its 50-day moving average of $1.77 and -28.46% below from the stock’s 200-day moving average of $1.44. The company has Relative Strength Index (RSI 14) of 29.29 along with Average True Range (ATR 14) of 0.16. Its weekly and monthly volatility is 8.04%, 12.05% respectively. The company’s beta value is at 2.05.

Bonanza Creek Energy Inc (NYSE:BCEI)’s price to sales ratio for trailing twelve months is 0.27 and price to book ratio for most recent quarter is 2.69, whereas price to cash per share for the most recent quarter is 0.65. Bonanza Creek Energy Inc (NYSE:BCEI)’s quick ratio for most recent quarter is 0.10 along with current ratio for most recent quarter of 0.10. Total debt to equity ratio of the company for most recent quarter is 51.59 whereas long term debt to equity ratio for most recent quarter is 0.00. Bonanza Creek Energy Inc (NYSE:BCEI) has a Return on Assets of -15.70%. The company currently has a Return on Equity of -205.90% and Return on Investment of -12.30%.

Analysts Recommendation on: Delphi Automotive PLC (NYSE:DLPH)

Delphi Automotive PLC (NYSE:DLPH) soared 0.44% during previous trade, a total of 2.18M shares exchanged hands compared with its average trading volume of 1.92M shares whereas its relative volume is 1.11. The stock has a market capitalization of $21.91B along with 269M outstanding shares. Stock’s intraday price range hit the peak level of $82.48 and touched the lowest level of $80.76.

Most recently Delphi Automotive PLC (NYSE:DLPH)’s price target was revised on 3/17/17 and according to 20 analysts stock’s price will reach at $85.60 during 52 weeks with standard deviation of 11.40. Stock’s minimum price target estimates has been figured out at $60 while the maximum price target forecast is established at $100, if we look at the price target with an optimistic approach it has upside potential of 29% from its latest closing price of $81.85.

Historically, if we look at price target revisions, one week ago Delphi Automotive PLC (NYSE:DLPH)’s price target was revised on 2/28/17 by the analysts, however the bullish price estimates of the stock set at $100 while the bearish estimates kept at $60 over the next one year. Stock’s 52-week target was retained at $83.29, the estimates indicates a standard deviation of 11.06.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.69. ABR value is precisely based on brokerage recommendations, where out of 16 brokerage recommendations 12 rate Delphi Automotive PLC (NYSE:DLPH) stock a Strong Buy, 0 rate the stocks of the company a Buy, 2 rate Hold, 1 rate Sell and 1 recommend a Strong Sell. Most recently on 11/29/16 the stock of Delphi Automotive PLC (NYSE:DLPH) downgraded by Morgan Stanley from Equal-Weight to Underweight. However previously on 11/9/16 it was downgraded by BofA/Merrill from Buy to Underperform. A research note issued on 3/5/16 the stock was upgraded by UBS from Neutral to Buy.

Delphi Automotive PLC (NYSE:DLPH) performance over the past one year soared 13.88% whereas its year to date (YTD) performance indicated a bullish trend of 22.03%. During the last six months the stock climbed 19.44%. Quarterly performance of the company shows optimistic momentum of 19.46% while its last one month trend is positive with 7.34%. Stock’s weekly performance expressed up trend of 6.17%.

The company’s price sits 10.51% above from its 50-day moving average of $70.05 and 19.57% far from the stock’s 200-day moving average which is $70.22. Delphi Automotive PLC (NYSE:DLPH)’s shares are currently trading -1.66% away from the 52-week high price of $83.23 and +42.84% far from the 52-week low price of $57.30.

According to consensus agreement of 20 analysts Delphi Automotive PLC (NYSE:DLPH) will report earnings per share of $1.45 in their quarterly report and it is expected to announce the company’s results on 5/3/17. For the current quarter the company has high EPS estimates of $1.49 in contradiction of low EPS estimates of $1.39. However a year ago for the same quarter the company has reported $1.36 EPS. Current year EPS projections for Delphi Automotive PLC (NYSE:DLPH) set at $6.53 according to the sentiments of 24 analysts, while its lowest earnings estimates are $6.25 and highest earnings estimates are $6.8.

According to 19 analysts, Delphi Automotive PLC (NYSE:DLPH)’s revenue estimates for the current quarter are $4.1B meanwhile the company has high revenue estimates of $4.19B in contradiction of low revenue estimates of $4.04B. For the current year the company’s revenue estimates are $16.78B compared to low analyst estimates of $16.58B and high estimates of $17.05B according to the projection of 23 analysts.

Analysts Weigh in on: Analog Devices, Inc. (NASDAQ:ADI)

Analog Devices, Inc. (NASDAQ:ADI) soared 0.65% during previous trade, a total of 4.18M shares exchanged hands compared with its average trading volume of 3.12M shares whereas its relative volume is 1.57. The stock has a market capitalization of $30.11B along with 365.09M outstanding shares. Stock’s intraday price range hit the peak level of $83.33 and touched the lowest level of $82.73.

Most recently Analog Devices, Inc. (NASDAQ:ADI)’s price target was revised on 03/16/17 and according to 26 analysts stock’s price will reach at $89.96 during 52 weeks with standard deviation of 6.84. Stock’s minimum price target estimates has been figured out at $76 while the maximum price target forecast is established at $103, if we look at the price target with an optimistic approach it has upside potential of 24% from its latest closing price of $83.26.

Historically, if we look at price target revisions, two weeks ago Analog Devices, Inc. (NASDAQ:ADI)’s price target was revised on 2/22/17 by the analysts, however the bullish price estimates of the stock set at $99 while the bearish estimates kept at $64 over the next one year. Stock’s 52-week target was retained at $86.88, the estimates indicates a standard deviation of 8.15.

While taking an overview of recommendation trends, the stock currently has an average brokerage recommendation of 1.69. ABR value is precisely based on brokerage recommendations, where out of 18 brokerage recommendations 10 rate Analog Devices, Inc. (NASDAQ:ADI) stock a Strong Buy, 3 rate the stocks of the company a Buy, 5 rate Hold, 0 rate Sell and 0 recommend a Strong Sell. Most recently on 2/16/17 the stock of Analog Devices, Inc. (NASDAQ:ADI) downgraded by Wells Fargo from Outperform to Market Perform. However previously on 11/23/16 it was upgraded by BofA/Merrill from Neutral to Buy. A research note issued on 7/27/16 the stock was upgraded by Goldman from Sell to Neutral.

Analog Devices, Inc. (NASDAQ:ADI) performance over the past one year soared 47.51% whereas its year to date (YTD) performance indicated a bullish trend of 15.28%. During the last six months the stock climbed 34.38%. Quarterly performance of the company shows optimistic momentum of 15.41% while its last one month trend is positive with 2.59%. Stock’s weekly performance expressed up trend of 1.29%.

The company’s price sits 7.29% above from its 50-day moving average of $80.41 and 24.88% far from the stock’s 200-day moving average which is $70.80. Analog Devices, Inc. (NASDAQ:ADI)’s shares are currently trading -1.16% away from the 52-week high price of $84.24 and +62.44% far from the 52-week low price of $51.25.

According to consensus agreement of 10 analysts Analog Devices, Inc. (NASDAQ:ADI) will report earnings per share of $0.84 in their quarterly report and it is expected to announce the company’s results on 5/17/17. For the current quarter the company has high EPS estimates of $0.88 in contradiction of low EPS estimates of $0.78. However a year ago for the same quarter the company has reported $0.64 EPS. Current year EPS projections for Analog Devices, Inc. (NASDAQ:ADI) set at $3.97 according to the sentiments of 13 analysts, while its lowest earnings estimates are $3.71 and highest earnings estimates are $4.19.

According to 10 analysts, Analog Devices, Inc. (NASDAQ:ADI)’s revenue estimates for the current quarter are $1.11B meanwhile the company has high revenue estimates of $1.13B in contradiction of low revenue estimates of $1.07B. For the current year the company’s revenue estimates are $4.9B compared to low analyst estimates of $4.69B and high estimates of $4.99B according to the projection of 11 analysts.

What Analysts Suggest About Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)?

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) fell -0.48% during previous trade. JMP Securities issued rating on the stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in a research note issued to investors on Mar-17-17, the stock received “Upgrade” rating from Mkt Perform to Mkt Outperform. Additionally UBS issued their verdict on the stock of the company, on record date of Mar-09-17 the stock was “Initiated” as Buy at $106 besides that on Mar-01-17 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was “Initiated” by Citigroup as Buy at $105. Furthermore on Jan-26-17 the stock was “Reiterated” by Stifel as Buy from $108 to $100.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares ended last trading session at the price of $91.92 whereas a number of traders indicating mean target price will hit $99.70 over the next twelve months, mean value of price target most recently revised on 03/17/17. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s highest estimates of price target are $140 and low forecast is $75 based on the opinion of 22 analysts. The price target estimates represents a standard deviation of 17.71. However brokerage recommendations suggests an ABR of 2.19 based on calls of 18 experts, where 6 brokers polls the stock a Strong Buy, 2 suggest the stock a Buy, 10 suggest Hold, 0 are rating the stock as Sell while 0 as Strong Sell.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is expected to release the earnings of its current quarter on 4/26/17. The company is expected to release $0.39 EPS for current quarter according to 21 analysts whereas the company reported $0.09 EPS during same quarter a year ago. For the current quarter the stock has lowest EPS estimates of $0.23 and high estimate of $1.21. For the current year Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has set to release EPS of $1.66 as per the sentiments of 25 analysts, however according to 22 analysts, the company expected to release $2.95 EPS for next year.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s average revenue estimates for the current quarter are $506.07M according to 20 number of analysts. However its lowest revenue estimates are $448M and highest revenue estimates are $709.27M. A year ago the company’s sales were $397.15M. Its yearly sales growth estimates are 27.40%. For the next quarter the company has anticipated average revenues of $487.01M, according to the sentiments of 21 analysts. For the current year the company has fixed $2.03B revenues, as per the opinion of 26 analysts. For the current year the company has low revenue estimates of $1.9B in contradiction of high revenue estimates of $2.29B. Whereas for the next year revenues are set at $2.54B by 23 analysts.

The stock exchanged hands 2.50M shares versus average trading capacity of 1.49M shares, while its shares’ total market worth is $22.73B along with 248.44M outstanding shares. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares were trading -11.39% below from the 52-week high price mark of $103.73 and +28.63% above from the 52-week price bottom of $71.46. However the company observed 52 week high price on 08/09/16 and witnessed 52 week low price on 12/22/16. The company’s price sits 5.98% above from its 50-day moving average of $89.17 and 4.75% far from the stock’s 200-day moving average which is $85.12. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)’s price to sales ratio for trailing twelve month stands at 13.42, whereas its price to book ratio for most recent quarter sits at 19.47. However the company’s price to cash per share for most recent quarter stands at 15.92. Its price to free cash flow for trailing twelve months is 127.22.